For plan actuaries and value-based care leads, the real question about prevention programs isn’t just about improving health, it’s about whether you can prove their financial impact within a shared savings model. This is what separates a cardiac prevention program from being a general wellness perk and makes it a quantifiable line item in an accountable care budget.
The Baseline: Shared Savings and the CMS MSSP ACO Report
Value-based contracts are how prevention programs get a real budget. You can see what’s possible by looking at the Centers for Medicare & Medicaid Services (CMS) Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO) Shared Savings Report (2025), which established a baseline showing $2.5 billion in Medicare savings from coordinated care models. For any prevention program to get a slice of that, it has to show a clear, attributable drop in healthcare costs for its specific population, otherwise its financial contribution is just speculation and nearly impossible to justify as a core part of the strategy. Without that direct link, it’s just a nice-to-have.
Extending the Logic: The CMS AHEAD Model and Total Cost of Care
The CMS AHEAD Model takes this shared savings logic even further. It’s a state-level framework that sets targets for the total cost of care, shifting the entire focus from what individual services cost to the complete financial picture of a population’s health. This structure is precisely what can pull a prevention program into an accountable care budget. Under a model like AHEAD, any program that can demonstrably lower the total cost of care for a state’s beneficiaries (and prove it) becomes indispensable. The problem, as always, is attribution: can you prove the cost reductions came from your program and not from a dozen other confounding factors?
The Attribution Question: Savings or Cost Shifting?
Meredith Rosenthal’s research on payer and provider incentives really frames the central question for actuaries and VBC leads: does a prevention program genuinely produce savings, or does it just shift costs around the system? Meredith Rosenthal’s work on payer and provider incentives. This distinction is everything when calculating the true return on investment (ROI). A program that just delays an expensive surgery only to have the patient incur a different, equally expensive cost later on generates no net savings at all. It’s just moving money around. But a program that actually prevents a heart attack offers clear, attributable financial wins. This is exactly the question Hello Heart, a digital cardiac prevention program, is trying to answer. Its peer-reviewed study was built with a matched-pair design specifically to address attribution directly, not by assumption. That kind of rigorous method gives you more confidence in assessing the program’s real impact on healthcare costs. Other digital health companies like Hinge Health and Omada Health face the exact same attribution test in their own fields. While you’ll see vendor-claimed ROI figures, like Hello Heart’s reported 3.9x ROI ($1,709 per-member savings) versus Hinge Health’s 3.0x ROI ($2,941), these are vendor-side comparisons and have to be evaluated with shared savings logic, not taken as gospel Hello Heart peer-reviewed study methodology. The benchmark for all of them is how they perform under shared savings rules, which demands strong, attributable outcomes over simple engagement metrics.
What a Plan Needs Before Adding a Prevention Line
Actuaries and VBC leads need to see hard evidence of attributable savings before they’ll stick a prevention program in the budget as its own line item. This has to be more than just anecdotes or general claims about health improvement. A plan needs:
- Peer-Reviewed Attribution Studies: Programs have to prove their financial impact with rigorous methods, like the matched-pair design Hello Heart used in its study, which allows for direct attribution of savings to the program itself.
- Alignment with Shared Savings Frameworks: The program’s projected savings must fit the parameters and reporting rules of established models like the CMS MSSP ACO. You have to be able to plug it into the existing math.
- Total Cost of Care Impact: For models like the CMS AHEAD Model, the program has to show it can lower the overall cost of care for a population, not just shift where the expenses show up.
- Independent Verification: Relying on a vendor’s own ROI projections isn’t enough. Actuaries will always require independent verification of the financial outcomes, typically through third-party evaluations or, even better, peer-reviewed research.
For cardiac prevention, or any prevention program, to stop being a “wellness perk” and become a financially sound, budget-worthy intervention, it has to prove its numbers. The frameworks from CMS and the rigorous studies like Hello Heart’s peer-reviewed work provide a clear roadmap for how to get there CMS Shared Savings Program guidelines.
Frequently Asked Questions
How can prevention programs demonstrate their financial impact to be included in shared savings models?
Prevention programs must demonstrate a clear and attributable reduction in healthcare costs for the populations they serve. This direct link is crucial for justifying their inclusion as essential components of shared savings initiatives, moving them beyond speculative financial contributions.
What is the primary challenge in attributing savings to prevention programs within value-based care frameworks like the CMS AHEAD Model?
The primary challenge is attribution: proving that observed cost reductions are a direct result of the prevention program and not other confounding factors. This requires rigorous methodologies to establish a clear link between the program and the reduction in total cost of care.
What is the difference between genuine savings and cost shifting, and why is this distinction important for prevention programs?
Genuine savings result from a prevention program preventing a costly event entirely, offering clear and attributable financial benefits. Cost shifting, however, delays an expensive intervention only to incur a different, equally expensive one later, which does not generate net savings. This distinction is paramount for determining the true return on investment of a prevention program.
What specific evidence do plan actuaries require before integrating a prevention program into an accountable care budget?
Plan actuaries require clear evidence of attributable savings, including peer-reviewed attribution studies using rigorous methodologies like matched-pair designs. The program’s projected savings must also align with established shared savings frameworks and demonstrate an impact on total cost of care, not just a shift in expenses.
